Browse diseases

…Introduction Hepatocellular carcinoma (HCC) incidence in the UK has increased by 50% over the past de…

…practice in this patient group. Cohort studies predominantly in atrial fibrillation suggest anticoagulation reduces stroke risk and improves surviv…

…tension, obesity/overweight, COPD, MASLD/MASH, liver cirrhosis, hepatocellular carcinoma, cardiovascular disease, chronic kidney disease, non-liver canc…

…n/1.73 m2, p<0.0001), associated with a more complex history of cirrhosis complications, with ascites occurring in 76.5% of CKD+ versus 6…

…s, or clinical determination by the investigator. Patients with cirrhosis were identified as having signs of PHT at baseline if they had …

…ad liver disease: 88 had steatosis only, 21 had AH, and 171 had cirrhosis. Of the cirrhosis patients, 103 had compensated and 68 had deco…

…without portal hypertension or synthetic failure), and stage 3 (cirrhosis with portal hypertension but without decompensation). Late-stag…

…nt and treatment was poor, particularly regarding post-fracture osteoporosis therapy and specialist referrals.Conclusion This audit reveals …

…ission due to decompensation in patients managed in a dedicated cirrhosis service. Ensemble models can stratify risk of admission, allowi…

…ions Osteoporotic fracture can be a devastating complication of cirrhosis. In this study we found 44% of individuals were vitamin D defic…

…ract P60 Figure 1Cumulative incidence functions (CIFs) for MASL/MASH progression to cirrhosis and composite events stratified by the…

…elect patients for surveillance.Methods All patients with a new HCC diagnosis from our regional MDM were included from Sept 24-25. …